Synthesis of acyclic 6,7-dihaloquinolone nucleoside analogues as potential antibacterial and antiviral agents

Bioorganic and Medicinal Chemistry

Volumn 8, Issue 6, 2000, Pages 1407-1413

  Al Masoudi, Najim A ^a   Al Soud, Yaseen A ^b   Eherman, Michael ^a   De Clercq, Erik ^c  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b AL AL BAYT UNIVERSITY   (Jordan)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; NALIDIXIC ACID; NUCLEOSIDE ANALOG; QUINOLONE DERIVATIVE; ZIDOVUDINE;

ANTIBACTERIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CYTOTOXICITY; DRUG SYNTHESIS; ESCHERICHIA COLI; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

ANTI-INFECTIVE AGENTS; ANTIVIRAL AGENTS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; NUCLEOSIDES; QUINOLONES; SPECTRUM ANALYSIS;

EID: 0034131291     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(00)00067-5     Document Type: Article

References (43)

1. Smith, T. J.; Lewin, C. S. In The Quinolones; Andriole, V. T., Ed.; Academic: London, 1988; Chapter 2.
2. Lesher G.Y., Froelich E.J., Gruett M.D., Bailey J.H., Brundage R.P. J. Med. Chem. 5:1962;1063.
3. Nasr M., Drach J.C., Smith S.H., Shipman C., Burckhalter J.H. J. Med. Chem. 31:1988;1347.
4. Baker B.R., Bramhall R.R. J. Med. Chem. 15:1972;230.
5. Koga H., Itoh A., Murayama S., Suzue S., Ivikura T. J. Med. Chem. 23:1980;1358.
6. Wise R., Andrews J.M., Edwards L. J. Antimicrob. Agents Chemother. 23:1983;559.
7. Wentland M.P., Bailey D.M., Cornett J.B., Dobson R.A., Powles R.G., Wagner R.B. J. Med. Chem. 27:1984;1103.
8. Miyamoto T., Matsumoto J., Chiba K., Egawa E., Shibamori K., Minamida A., Nishimura Y., Okada H., Kataoka M., Fuzita M., Hirose T., Nakano J. J. Med. Chem. 33:1990;1645.
9. Fujita M., Egawa H., Miyamoto T., Nakano J., Matsumoto J.I. Chem. Pharm. Bull. 44:1996;987.
10. de la Cruz, A.; Elguero, J.; Goya, P.; Martinez, A.; De Clercq, E. J. Chem. Soc., Perkin. Trans. 1 1993, 845 and references therein.
11. da Matta A.D., Bernardino A.M.R., Romeiro G.A., de Oliveira M.R.P., de Souza M.C.B.V., Ferreira V.F. Nucleosides Nucleotides. 15:1996;889.
12. Al-Masoudi N.A., Al-Soud Y.A., Ehermann M., DeClercq E. Nucleosides Nucleotides. 17:1998;2255.
13. Schaeffer H.J., Beauchamp L., De Miranda P., Elion G.B., Bauer D.J., Collins P. Nature (London). 272:1987;583.
14. Martin J.C., Dvorak C.A., Smee D.F., Mattews T.R., Verheyden J.P.H. J. Med. Chem. 26:1983;759.
15. Keller P.M., Fyfe J.A., Beauchamp L., Lubbers C.M., Furman P.A., Schaeffer H.J., Elion G.B. Biochem. Pharmacol. 30:1981;3071.
16. Reines E.D., Gross P.A. Antiviral Agents Med. Clin. North Am. 72:1988;691.
17. Kelsey J.E., Biron K.K., Collins P., Selway J., Lin J.-C., Schaeffer H.J. J. Med. Chem. 31:1988;144.
18. De Clercq E. Clin. Microbiol. Rev. 10:1997;674.
19. Ashton, W. T.; Canning, L. F.; Wagner, A. F.; Cantone, C.; Walton, E.; Patel, G. F.; Tolman, R. L.; Karkas, J. D.; Field, A.K. 192nd National Meeting of the American Chemical Society, Anaheim, CA, 7-12 September, 1986.
20. Hagberg, C.-E.; Johansson, K. N.-G.; Kovacs, Z. M. I.; Stening, G. B. European Patent 55 239; Bulletin 1982 82/26.
21. Johansson, K. N.-G.; Lindborg, B. G.; Noren, J.-O. European Patent 146 516; Bulletin 1985, 85/26.
22. Haines D.R., Tseng C.K.H., Marques V.E. J. Med. Chem. 30:1987;943.
23. Hua M., Korkowski P.M., Vince R. J. Med. Chem. 30:1987;198.
24. Phadtare S., Zemlicka J. J. Med. Chem. 30:1987;437.
25. Phadtare, S.; Zemlicka, J. Nucleic Acids, Symp. Ser. No. 18, 1987, 25.
26. Phadtare S., Fessel D., Zemlicka J. Nucleosides Nucleotides. 8:1989;907.
27. Zemlicka J. Nucleosides Nucleotides. 16:1997;1003.
28. Niedballa U., Vorbrüggen H. J. Org. Chem. 39:1974;3654.
29. Robins M.J., Hatfield P.W. Can. J. Chem. 60:1982;547.
30. de la Cruz, A.; Elguero, J.; Goya, P.; Martinez, A.; Gotor, V.; Moris, F.; De Clercq, E. J. Chem. Res. (S) 1992, 216; and J. Chem. Res. (M) 1992, 1682.
31. de la Cruz, A.; Elguero, J.; Goya, P.; Martinez, A.; Gotor, V.; Moris, F.; De Clercq, E. J. Chem. Res. (S) 1992, 216; and J. Chem. Res. (M) 1992, 1682.
32. (a). Rosowsky, A.; Kim, A.; Wick, M. J. Med. Chem. 1982, 24, 1177.
33. (b) Robins, M. J.; Hatfield, P. W. Can. J. Chem. 1982, 60, 547.
34. de la Cruz, A.; Elguero, J.; Goya, P.; Martinez, A.; Pfleiderer, W. Tetrahedron 1992, 48, 6135 and references therein cited.
35. Al-Masoudi N.A., Al-Soud Y.A., Geyer A. Spectroscopy Lett. 31:1998;1031.
36. Katrizky A.R., Ellison J., Frank J., Ra'ko'czy P., Radics L., Ga'cs-Baitz E. Org Mag. Res. 18:1981;280.
37. (a) De Clercq, E. Rev. Med. Virol. 1993, 3, 85.
38. (b) Snoeck, R.; Sakuma, T.; De Clercq, E.; Rosenberg, I.; Holy, A. Antimicrob. Agents Chemother. 1988, 32, 1839.
39. (a) Schinazi, R. F.; Mead, J. R.; Feorino, P. M. AIDS Res. Hum. Retroviruses 1992, 8, 963.
40. (b) Schinazi, R. F. Perspect. Drug Discovery Des. 1993, 1, 151-180.
41. De Clercq E., Descamps J., De Somer P., Barr P.J., Jones A.S., Walker R.T. Proc. Natl. Acad. Sci. USA. 76:1979;2947.
42. De Clercq E. Biochem. Pharmacol. 42:1991;963.
43. Sidwell R.W., Huffman J.H., Khare G.P., Allen L.B., Witkowski J.T., Robins R.K. Science. 177:1972;705.